Lysine Malonylation and SIRT5 in Epigenetic Regulation
表观遗传调控中的赖氨酸丙二酰化和 SIRT5
基本信息
- 批准号:9198466
- 负责人:
- 金额:$ 3.3万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-01-01 至 2017-02-28
- 项目状态:已结题
- 来源:
- 关键词:Acetyl-CoA CarboxylaseAcetylationActive SitesAgingAntibodiesBacteriaBindingBiologicalBiological AssayBiological ProcessCD4 Positive T LymphocytesCandidate Disease GeneCarnitine O-PalmitoyltransferaseCell NucleusCellsCellular Stress ResponseChIP-seqChargeChromatin StructureCultured CellsCytosolData SetDeacetylaseDesire for foodDiabetes MellitusDiseaseDropsEpigenetic ProcessFamily memberFastingFatty AcidsFollow-Up StudiesGene AbnormalityGene ExpressionGene Expression RegulationGenesGenetic TranscriptionGenomeGenomic SegmentGenomicsGlucoseHepatocyteHistone CodeHistone H1Histone H1(s)Histone H2BHistonesHumanHypothalamic structureKnockout MiceKnowledgeLightLinkLiverLysineMalonatesMalonyl Coenzyme AMapsMediatingMetabolicMetabolic DiseasesMetabolic syndromeMetabolismMitochondriaModelingModificationMolecular ConformationMusNicotinamide adenine dinucleotideNuclearNutritionalNutritional statusObesityPathologicPatternPhysiologicalProteinsProteomicsRegulationReportingResearch ProposalsRoleSIRT1 geneSirtuinsSiteSurveysTestingTissuesTranscription Initiation SiteTranscriptional Regulationbaseepigenetic regulationfatty acid biosynthesisfatty acid metabolismfatty acid oxidationfatty acid transportfeedinghistone modificationinsulin secretionknockout genemalonyl-CoA decarboxylasenormal agingnoveloverexpressionoxidationresponsetranscriptometranscriptome sequencing
项目摘要
PROJECT ABSTRACT
Epigenetic factors have emerged as crucial players in metabolic disorders and in aging, both of which are
typically associated with a wide range of gene expression changes. The overall objective of this proposal is to
investigate the roles of a novel histone modification, lysine malonylation, and its regulation by the NAD+-
dependent protein deacylase SIRT5, as a novel histone modifier in epigenetic regulation of gene expression in
response to metabolic changes. The model is based on our recent identification of histone H2B lysine 5
(H2BK5) as a site of malonylation regulated by SIRT5. We propose that the dynamic malonylation of histone
H2B by cellular malonyl-CoA and demalonylation by SIRT5 regulates chromatin structure and gene
transcription. Two specific aims are developed to test this model globally in mouse liver and then
mechanistically in cultured cells. First, genomic regions bound with malonylated histones (H2BK5) and SIRT5
will be compared using ChIP-seq using tissues from wild type and Sirt5-/- mice. These studies will aim to
identify the sites of SIRT5-mediated histone demalonylation. The functional consequences of histone
malonylation will be evaluated by comparing gene transcriptional changes using RNA-seq between wild type
and Sirt5-/- mice. This data set will be compared to the sites where SIRT5 binds to the genome and
demalonylates histones to identify the direct genomic sites of SIRT5 action. Second, we will study in
mechanistic details how histone malonylation is dynamically regulated by SIRT5 and by fluctuations in cellular
malonyl-CoA that occur during feeding and fasting in mice. In primary cultured mouse hepatocytes, we will also
test the effect of feeding malonate (which is converted into malonyl-CoA intracellularly) and the effect of
manipulating the cellular synthesis or degradation of malonyl-CoA via acetyl-CoA carboxylase (synthesis) and
malonyl-coA decarboxylase (degradation).
This research proposal takes the first step towards understanding the function of this newly discovered histone
modification, malonylation, and its eraser, SIRT5, in epigenetic regulation. It will contribute significantly to our
longstanding effort of unveiling the “histone code”, its intersection with intermediary metabolism, and to
advance our knowledge of gene expression regulation by epigenetic factors. Results from the proposed project
will therefore permit mechanistic follow-up studies of the significance of histone malonylation and SIRT5 in
epigenetic regulation and how dysregulation may contribute to both pathological conditions, such as metabolic
syndrome and diabetes, and to normal aging.
项目摘要
表观遗传因素已成为代谢性疾病和衰老的关键参与者
通常与广泛的基因表达变化有关。该提议的总体目的是
研究一种新型组蛋白修饰,赖氨酸误导性及其对NAD+ - 调节的作用
依赖性蛋白脱酰基酶SIRT5,是一种新型组蛋白修饰剂,在基因表达的表观遗传调节中
对代谢变化的反应。该模型基于我们最近对组蛋白H2B赖氨酸5的鉴定
(H2BK5)作为由SIRT5调节的误导地点。我们建议组蛋白的动态误犬
H2B通过细胞丙二酰辅-COA和SIRT5的销售量调节染色质结构和基因
转录。开发了两个具体目标,以在小鼠肝脏中全球测试该模型,然后
在培养细胞中机械上。首先,基因组区域与丙二酰化组蛋白(H2BK5)和SIRT5结合
使用芯片seq使用野生型和SIRT5 - / - 小鼠的组织进行比较。这些研究将旨在
识别SIRT5介导的Hisstone命令的地点。组蛋白的功能后果
将通过使用RNA-Seq在野生型之间比较基因转录变化来评估误习
和SIRT5 - / - 小鼠。将将此数据集与SIRT5与基因组结合的站点进行比较
将组蛋白划分为识别SIRT5作用的直接基因组位点。其次,我们将学习
机械详细说明了Hisstone Malonylation如何通过SIRT5和细胞波动动态调节
在小鼠的喂养和禁食期间发生的丙二酰coA。在原发性培养的鼠标肝细胞中,我们也将
测试丙二这酸盐的效果(细胞内转化为丙二酰辅酶A)和
通过乙酰辅酶A羧化酶(合成)和
malonyl-COA脱羧酶(降解)。
该研究建议迈出了了解这个新发现的组蛋白功能的第一步
在表观遗传调节中的修饰,误导及其橡皮sirt5。它将为我们的
长期以来揭示“组蛋白代码”,与中间代谢的交集以及
通过表观遗传因素提高我们对基因表达调节的了解。拟议项目的结果
因此,将允许对组蛋白误导和SIRT5的重要性的机械随访研究
表观遗传调节以及失调可能导致两种病理状况,例如代谢
综合征和糖尿病,以及正常衰老。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Eric M. Verdin其他文献
Eric M. Verdin的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Eric M. Verdin', 18)}}的其他基金
Senescence, NAD+ decrease and Alzheimer's disease and related dementias Alzheimer's disease and related dementias
衰老、NAD 减少与阿尔茨海默病和相关痴呆症 阿尔茨海默病和相关痴呆症
- 批准号:
10187413 - 财政年份:2021
- 资助金额:
$ 3.3万 - 项目类别:
Senescence, NAD+ decrease and Alzheimer's disease and related dementias Alzheimer's disease and related dementias
衰老、NAD 减少与阿尔茨海默病和相关痴呆症 阿尔茨海默病和相关痴呆症
- 批准号:
10491086 - 财政年份:2021
- 资助金额:
$ 3.3万 - 项目类别:
Senescence, NAD+ decrease and Alzheimer's disease and related dementias Alzheimer's disease and related dementias
衰老、NAD 减少与阿尔茨海默病和相关痴呆症 阿尔茨海默病和相关痴呆症
- 批准号:
10647780 - 财政年份:2021
- 资助金额:
$ 3.3万 - 项目类别:
Identification of HIV latency biomarkers with a dual fluorescence reporter HIV
使用双荧光报告基因 HIV 鉴定 HIV 潜伏生物标志物
- 批准号:
9231361 - 财政年份:2015
- 资助金额:
$ 3.3万 - 项目类别:
Identification of HIV latency biomarkers with a dual fluorescence reporter HIV
使用双荧光报告基因 HIV 鉴定 HIV 潜伏生物标志物
- 批准号:
8892911 - 财政年份:2015
- 资助金额:
$ 3.3万 - 项目类别:
相似国自然基金
仙茅酚苷类成分靶向组蛋白去乙酰化酶HDAC1抑制BMSC衰老防治老年性骨质疏松的机制
- 批准号:82304806
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
丁酸上调HSD11b2乙酰化抑制HPA轴激活改善孤独症样社交障碍机制研究
- 批准号:82372559
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
ACSS2介导的乙酰辅酶a合成在巨噬细胞组蛋白乙酰化及急性肺损伤发病中的作用机制研究
- 批准号:82370084
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
高糖水平通过JUN乙酰化修饰上调NCAPD3促进结直肠癌发生的分子机制
- 批准号:82303250
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
芪苓温肾消囊颗粒通过HDAC5调控GATA1启动子区H3K27乙酰化改善PCOS妊娠早期流产的机制研究
- 批准号:82374498
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
相似海外基金
Role of BRD4 in Normal Hematopoiesis and Hematopoietic Stem Cell Biology_
BRD4在正常造血和造血干细胞生物学中的作用_
- 批准号:
10610534 - 财政年份:2022
- 资助金额:
$ 3.3万 - 项目类别:
Discovery of small molecule inhibitors for protein N-terminal acetyltransferase D
蛋白质 N 末端乙酰转移酶 D 小分子抑制剂的发现
- 批准号:
10366567 - 财政年份:2021
- 资助金额:
$ 3.3万 - 项目类别:
Targeting durotaxis in lung injury and fibrosis
靶向肺损伤和纤维化中的杜罗轴
- 批准号:
10364927 - 财政年份:2021
- 资助金额:
$ 3.3万 - 项目类别:
Targeting durotaxis in lung injury and fibrosis
靶向肺损伤和纤维化中的杜罗轴
- 批准号:
10532249 - 财政年份:2021
- 资助金额:
$ 3.3万 - 项目类别:
Discovery of small molecule inhibitors for protein N-terminal acetyltransferase D
蛋白质 N 末端乙酰转移酶 D 小分子抑制剂的发现
- 批准号:
10532369 - 财政年份:2021
- 资助金额:
$ 3.3万 - 项目类别: